Literature DB >> 33230082

Medical Management of Chronic Pancreatitis in Children: A Position Paper by the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Pancreas Committee.

A Jay Freeman1, Asim Maqbool2, Melena D Bellin3, Kenneth R Goldschneider4, Amit S Grover5, Cheryl Hartzell6, Travis L Piester7, Flora Szabo8, Bridget Dowd Kiernan2, Racha Khalaf9, Rakesh Kumar10, Mirta Rios11, Sohail Z Husain12, Veronique D Morinville13, Maisam Abu-El-Haija14.   

Abstract

ABSTRACT: This position paper summarizes the current understanding of the medical management of chronic pancreatitis (CP) in children in light of the existing medical literature, incorporating recent advances in understanding of nutrition, pain, lifestyle considerations, and sequelae of CP. This article complements and is intended to integrate with parallel position papers on endoscopic and surgical aspects of CP in children. Concepts and controversies related to pancreatic enzyme replacement therapy (PERT), the use of antioxidants and other CP medical therapies are also reviewed. Highlights include inclusion of tools for medical decision-making for PERT, CP-related diabetes, and multimodal pain management (including an analgesia ladder). Gaps in our understanding of CP in children and avenues for further investigations are also reviewed.
Copyright © 2020 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Entities:  

Mesh:

Year:  2021        PMID: 33230082      PMCID: PMC8054312          DOI: 10.1097/MPG.0000000000003001

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   3.288


  150 in total

Review 1.  Pancreatic pseudocysts in the 21st century. Part I: classification, pathophysiology, anatomic considerations and treatment.

Authors:  Ake Andrén-Sandberg; Christos Dervenis
Journal:  JOP       Date:  2004-01

2.  Definitions of pediatric pancreatitis and survey of present clinical practices.

Authors:  Veronique D Morinville; Sohail Z Husain; Harrison Bai; Bradley Barth; Rabea Alhosh; Peter R Durie; Steven D Freedman; Ryan Himes; Mark E Lowe; John Pohl; Steven Werlin; Michael Wilschanski; Aliye Uc
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-09       Impact factor: 2.839

3.  [Cancer pain: therapy according to the pain relief ladder].

Authors:  Hans-Ulrich Giesen
Journal:  MMW Fortschr Med       Date:  2010-05-27

4.  ESPGHAN and NASPGHAN Report on the Assessment of Exocrine Pancreatic Function and Pancreatitis in Children.

Authors:  Christopher J Taylor; Kathy Chen; Karoly Horvath; David Hughes; Mark E Lowe; Devendra Mehta; Abrahim I Orabi; Jeremy Screws; Mike Thomson; Stephanie Van Biervliet; Henkjan J Verkade; Sohail Z Husain; Michael Wilschanski
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-07       Impact factor: 2.839

5.  Insulin resistance is a prominent feature of patients with pancreatogenic diabetes.

Authors:  H Yki-Järvinen; T Kiviluoto; M R Taskinen
Journal:  Metabolism       Date:  1986-08       Impact factor: 8.694

6.  B cell function in patients with chronic pancreatitis and its relation to exocrine pancreatic function.

Authors:  B Nyboe Andersen; T Krarup; N T Thorsgaard Pedersen; O K Faber; C Hagen; H Worning
Journal:  Diabetologia       Date:  1982-08       Impact factor: 10.122

7.  The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance.

Authors:  Filip K Knop; Tina Vilsbøll; Patricia V Højberg; Steen Larsen; Sten Madsbad; Jens J Holst; Thure Krarup
Journal:  Regul Pept       Date:  2007-07-13

Review 8.  Alcohol as a risk factor for pancreatitis. A systematic review and meta-analysis.

Authors:  Hyacinth M Irving; Andriy V Samokhvalov; Jürgen Rehm
Journal:  JOP       Date:  2009-07-06

9.  The Roles of Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography in the Evaluation and Treatment of Chronic Pancreatitis in Children: A Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Pancreas Committee.

Authors:  Quin Y Liu; Roberto Gugig; David M Troendle; Samuel Bitton; Nishant Patel; David S Vitale; Maisam Abu-El-Haija; Sohail Z Husain; Veronique D Morinville
Journal:  J Pediatr Gastroenterol Nutr       Date:  2020-05       Impact factor: 2.839

10.  Absorption and Safety With Sustained Use of RELiZORB Evaluation (ASSURE) Study in Patients With Cystic Fibrosis Receiving Enteral Feeding.

Authors:  John Stevens; Colby Wyatt; Perry Brown; Dhiren Patel; Danica Grujic; Steven D Freedman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-10       Impact factor: 2.839

View more
  5 in total

1.  An assessment of pancreatology education in North American pediatric gastroenterology fellowship programs.

Authors:  Puanani Hopson; Chris Moreau; Cemal Yazici; Samuel Han; Venkata Akshintala; Livia Archibugi; Peter Lee; Aliye Uc
Journal:  Pancreatology       Date:  2021-10-31       Impact factor: 3.996

2.  Significant Published Articles in 2021 for Pharmacy Nutrition Support Practice.

Authors:  Roland N Dickerson; Angela L Bingham; Todd W Canada; Lingtak Neander Chan; M Petrea Cober; Sarah V Cogle; Anne M Tucker; Vanessa J Kumpf
Journal:  Hosp Pharm       Date:  2022-06-04

Review 3.  Hereditary pancreatitis: An updated review in pediatrics.

Authors:  Arvind Vasant Panchoo; Grant H VanNess; Edgardo Rivera-Rivera; Trevor J Laborda
Journal:  World J Clin Pediatr       Date:  2022-01-09

Review 4.  Pancreatogenic Diabetes in Children With Recurrent Acute and Chronic Pancreatitis: Risks, Screening, and Treatment (Mini-Review).

Authors:  Melena D Bellin
Journal:  Front Pediatr       Date:  2022-04-26       Impact factor: 3.418

Review 5.  Complications of chronic pancreatitis in children.

Authors:  Emily Perito; Tanja Gonska; Melena D Bellin; Sarah Jane Schwarzenberg
Journal:  Curr Opin Gastroenterol       Date:  2021-09-01       Impact factor: 2.741

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.